...
首页> 外文期刊>Bioengineered >MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary sj?gren’s syndrome
【24h】

MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary sj?gren’s syndrome

机译:MicroRNA-146A-5P通过在原发生SJ中的17级降低17水平来增强T Helper 17细胞分化?GREN的综合征

获取原文
           

摘要

In clinical practice, we found that microRNA (miR)-146a-5p is significantly up-regulated in peripheral blood mononuclear cells (PBMCs) of primary sj?gren’s syndrome (pSS) patients. In vitro experiments confirmed that miR-146a-5p promotes T helper 17 (Th17) cell differentiation, but the specific mechanism is still unknown. To solve this problem, 20 pSS patients and 20 healthy subjects were enrolled in this study and PBMCs were isolated from their blood. The expression of the membrane IL-23?R (mIL-23?R) in PBMCs was determined. CD3~(+) T cells were also isolated and used to further analyze the relationship between the ectodomain shedding of mIL-23?R and a disintegrin and metalloprotease 17 (ADAM17). Finally, miR-146a-5p inhibitor and mimics were transfected into PBMCs to evaluate the relationship between ADAM17 and mIL-23?R, and explore the role of mIL-23?R and ADAM17 in Th17 cell differentiation. Our results revealed a significantly increased expression of miR-146a-5p in PBMCs from pSS patients and significantly increased percentage of Th17 cells compared to PBMCs from healthy controls. Under polarization culture conditions, pSS patient-derived PBMCs can more easily differentiate into Th17 cells, which was, to a great extent, attributable to the increased expression of mIL-23?R. Moreover, ADAM17, an ectodomain sheddase of mIL-23?R, was targeted and negatively regulated by miR-146a-5p, which reduced the ectodomain shedding of mIL-23?R. Overall, our results suggested that miR-146a-5p could promote Th17 cell differentiation through targeting and negatively regulating ADAM17. Thus, these results might offer a new approach in the treatment of pSS.
机译:在临床实践中,我们发现MicroRNA(MIR)-146A-5P在原发性SJ的外周血单核细胞(PBMC)中显着上调?GREN的综合征(PSS)患者。 在体外实验证实,miR-146a-5p促进了t辅助17(th17)细胞分化,但具体机制仍然是未知的。为了解决这个问题,在本研究中注册了20 pss患者和20名健康受试者,并从血液中分离出PBMC。确定膜IL-23≤R(MIL-23≤R)在PBMC中的表达。还分离CD3〜(+)T细胞,并用于进一步分析静体脱落的静脉23Ω·r和Disintegrin和Metallopotease 17(Adam17)之间的关系。最后,将miR-146a-5p抑制剂和模拟物转染到PBMC中,以评估ADAM17和MIL-23的关系,并探讨MIL-23?R和ADAM17在Th17细胞分化中的作用。我们的研究结果显示,与PBMC患者的PBMC中miR-146a-5p表达显着增加,与来自健康对照的PBMC相比,Th17细胞的百分比显着增加。在偏振培养条件下,PSS患者衍生的PBMC可以更容易地分化成Th17细胞,即在很大程度上归因于MIL-23ΔR的增加。此外,ADAM17是MIR-23?R的突突划酶,由MiR-146A-5P靶向和负调节,其降低了MIL-23ΔR的突突引起的脱落。总体而言,我们的结果表明MiR-146A-5P可以通过靶向和负面调节ADAM17来促进Th17细胞分化。因此,这些结果可能在治疗PSS时提供一种新的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号